Explore

Trendline Trendline
PureTech's LYT-200 Shows Promise in Phase 1b Trial for High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia

PureTech's LYT-200 Shows Promise in Phase 1b Trial for High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia

PureTech's LYT-200 Shows Promise in Phase 1b Trial for High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia
Trendline Trendline
Lantern Pharma's LP-300 Shows Promising Results in Lung Cancer Trial, Seeks FDA Guidance

Lantern Pharma's LP-300 Shows Promising Results in Lung Cancer Trial, Seeks FDA Guidance

Lantern Pharma's LP-300 Shows Promising Results in Lung Cancer Trial, Seeks FDA Guidance
Reuters Reuters
US FDA approves Merck's pill combo to treat HIV infection

US FDA approves Merck's pill combo to treat HIV infection

April 21 (Reuters) - The U.S. Food and Drug Administration has approved Merck's once-daily, oral, combination regimen for HIV infections, the health regulator's website showed on Tuesday.
Trendline Trendline
FDA Grants Star Therapeutics Rare Pediatric and Breakthrough Therapy Designations for Von Willebrand Disease Treatment

FDA Grants Star Therapeutics Rare Pediatric and Breakthrough Therapy Designations for Von Willebrand Disease Treatment

FDA Grants Star Therapeutics Rare Pediatric and Breakthrough Therapy Designations for Von Willebrand Disease Treatment
Trendline Trendline
Star Therapeutics Gains FDA Designations for VGA039 in Von Willebrand Disease Treatment

Star Therapeutics Gains FDA Designations for VGA039 in Von Willebrand Disease Treatment

Star Therapeutics Gains FDA Designations for VGA039 in Von Willebrand Disease Treatment
Trendline Trendline
FDA Grants Fast Track Designation to Debiopharm's Ovarian Cancer Therapy

FDA Grants Fast Track Designation to Debiopharm's Ovarian Cancer Therapy

FDA Grants Fast Track Designation to Debiopharm's Ovarian Cancer Therapy
Trendline Trendline
Cosmo Pharmaceuticals Plans FDA Submission for Baldness Treatment After Positive Trial Results

Cosmo Pharmaceuticals Plans FDA Submission for Baldness Treatment After Positive Trial Results

Cosmo Pharmaceuticals Plans FDA Submission for Baldness Treatment After Positive Trial Results
Trendline Trendline
FDA Reviews Genentech's Gazyva for Systemic Lupus Erythematosus Treatment

FDA Reviews Genentech's Gazyva for Systemic Lupus Erythematosus Treatment

FDA Reviews Genentech's Gazyva for Systemic Lupus Erythematosus Treatment
Trendline Trendline
Debiopharm's Ovarian Cancer Treatment Receives FDA Fast Track Designation

Debiopharm's Ovarian Cancer Treatment Receives FDA Fast Track Designation

Debiopharm's Ovarian Cancer Treatment Receives FDA Fast Track Designation
Trendline Trendline
FDA Grants Priority Review for KEYTRUDA and Padcev Combination for Muscle-Invasive Bladder Cancer

FDA Grants Priority Review for KEYTRUDA and Padcev Combination for Muscle-Invasive Bladder Cancer

FDA Grants Priority Review for KEYTRUDA and Padcev Combination for Muscle-Invasive Bladder Cancer
Trendline Trendline
Revolution Medicine's Phase III Pancreatic Cancer Trial Results Boost Stock and Investor Confidence

Revolution Medicine's Phase III Pancreatic Cancer Trial Results Boost Stock and Investor Confidence

Revolution Medicine's Phase III Pancreatic Cancer Trial Results Boost Stock and Investor Confidence
Trendline Trendline
NEOK Bio Highlights Bispecific Antibody Drug Conjugate Pipeline at AACR 2026

NEOK Bio Highlights Bispecific Antibody Drug Conjugate Pipeline at AACR 2026

NEOK Bio Highlights Bispecific Antibody Drug Conjugate Pipeline at AACR 2026